Controlled-release oxycodone for the management of pediatric postoperative pain Michelle L. Czarnecki, MSN, RN, CPNP, Matthew D. Jandrisevits, PhD(c), MA, Sarah C. Theiler, PhD(c), MS, Myra Martz Huth, PhD, RN, Steven J. Weisman, MD Journal of Pain and Symptom Management Volume 27, Issue 4, Pages 379-386 (April 2004) DOI: 10.1016/j.jpainsymman.2003.08.007
Fig. 1 Percentage of patients who reported selected side effects 24 hours prior (n=62), 24 hours after (n=62), and 48 hours after (n=57) transition to oxycodone-CR. Data were collected from the sample over three separate time intervals, with differing n resulting from patient discharge prior to the third period. Journal of Pain and Symptom Management 2004 27, 379-386DOI: (10.1016/j.jpainsymman.2003.08.007)